Enterprise labeling technology became the focus of a new investment vehicle on Monday as Accel-KKR's RS2 Healthcare Partners completed a recapitalization of Loftware.

The transaction provides Loftware with additional resources to further develop its cloud-based platform and expand within highly regulated industries such as life sciences and consumer goods.

Loftware, headquartered in Portsmouth, New Hampshire, offers an end-to-end suite of enterprise labeling and artwork management solutions.

Its platform enables global organizations to design, manage, and print labels while maintaining compliance with regulatory standards.

The company serves thousands of customers, including many of the world's largest pharmaceutical, medical device, and consumer packaged goods firms.

Founded in 1986, Loftware built its reputation on barcode labeling technology before transitioning to a comprehensive cloud offering.

Demand for labeling and artwork management software has grown as pharmaceutical and medical device companies face tightening serialization and traceability requirements.

Loftware's cloud platform replaces legacy on-premise systems, allowing enterprises to streamline labeling across complex supply chains.

Accel-KKR, a private equity firm with a deep focus on software and technology-enabled services, launched RS2 Healthcare Partners to target investments in healthcare technology and adjacent verticals; the Loftware transaction reflects that strategy.

The recapitalization closed alongside the announcement.

Loftware's existing management team will continue to lead the company, and no changes to day-to-day operations are planned.